About the Transplant - Nephrology Fellowship Program
The transplant fellowship offered by the Division of Nephrology is certified by the American Society of Transplantation (AST)/American Society of Transplant Surgeons (ASTS). Our transplant program, the largest in the region, performs over 150 kidney transplants every year. A wide variety of transplant related therapies including kidney exchange, desensitization, ABO incompatible transplants, and HIV and HCV positive kidney transplants are performed.
The Virginia Commonwealth University Transplant Nephrology Fellowship Program provides an opportunity to pursue advanced training in clinical transplant nephrology and to undertake training in basic science research or clinical research. The program is designed for trainees who wish to receive outstanding educational training in order to pursue a career in either academic medicine or private practice.
Your training fellowship involves one year of training that integrates the six core competencies (patient care, medical knowledge, practice based learning and improvement, interpersonal and communication skills, professionalism, and systems based learning). Each fellow will participate in clinical training, teaching and scholarly activities. The training experience includes involvement in all aspects of pre-transplant care including list management, kidney donor evaluations and assessment and acceptance of deceased donor organs, as well as post-transplant care including performing biopsies and management of immunosuppression. The fellows get hands-on training in immunology through rotations in the HLA lab and transplant kidney biopsy assessments with pathology. Dedicated teaching in transplant infectious disease is also provided. Under faculty mentorship, each fellow is expected to participate in at least one research project which will usually result in a presentation at a national or international conference. Our sites of practice include in-patient and continuity clinics at VCUHS.
After one year of clinical training, our goal is for each fellow to have confidence in independently evaluating and managing patients with a wide variety of kidney transplant issues.
Program Goals & Objectives
Fellows will be trained in all aspects of care for the renal transplant patient, including – but not limited to – pre-transplant evaluation, list management, kidney donor evaluation, peri-operative kidney transplant management and post-transplant care including immunosuppression.
One year Transplant Nephrology Fellowship: Intended for an additional one year of focused, intensive transplant nephrology training after completion of an accredited general nephrology fellowship program.
You will rotate through transplant nephrology consults at VCUHS, pre-transplant evaluation clinics and post-transplant continuity clinics. You will also have a dedicated HLA lab rotation and a transplant infectious disease rotation.
Unique Learning Opportunities
Fellows also have the opportunity to rotate through:
- HLA lab (immunology)
- Transplant Infectious Disease
Nephrology Grand Rounds
This conference series is prepared on an annual basis with presentations given by internal and visiting faculty members and VCU Nephrology fellows. Transplant Nephrology Fellows present one to two times each year on topics of their choice.
This conference series is prepared on an annual basis with presentations given by internal and visiting faculty members and VCU transplant nephrology and surgery fellows. Transplant Nephrology fellows present two to three times each year on topics of their choice with the help of faculty mentorship.
Renal Biopsy Conference
Renal Biopsy Conference is held in lieu of Renal Grand Rounds the 4th Thursday of each month. This conference is led by Drs. Massey and Vinnikova jointly.
Faculty members select articles and assign one to each of two fellows each month. The fellow reviews and presents the article, which includes salient methods, results, discussion, and study dissection/critiques.
This monthly conference highlights the various research methods and techniques throughout the university. This will include lectures from Division faculty members, other researchers from VCU (outside of Nephrology) and often visiting physicians from outside institutions.
- Schmoyer CJ, Kumar D, Gupta G, Sterling RK. Diagnostic Accuracy of Non-Invasive Tests to Detect Advanced Hepatic Fibrosis in Patients With Hepatitis C and End-Stage Renal Disease. Clin Gastroenterol Hepatol. 2020 Feb 18. PMID: 32084602
- A Chachar, I Moinuddin, D Kumar. Unusual Case of Nocardial Brain Abscess a decade after Renal Transplant. Poster Presentation at the National Kidney Foundation (NKF) 2020 Spring Clinical Meetings (SCM20), New Orleans, LA. 03/2020
- Kamal L, Yu JW, Reichman TW, Kang L, Bandyopadhyay D, Kumar D, King A, Gautam U, Bhati C, Yakubu I, Lacy K, Levy M, Gupta G. Impact of Induction Immunosuppression strategies in Simultaneous Liver Kidney Transplantation. Transplantation. 2019 Apr 22. PMID: 31022149
- D. Kumar, F. Safavi, R. Sandhu, P. Halloran, I. Yakubu, M. Levy, I. Moinuddin, P. Kimball, L. Kamal, A. King, H. Massey, G. Gupta. Lack Of Response To Tocilizumab In Kidney Transplants With Chronic Antibody-mediated Rejection. Poster presentation at Kumar, Dhiren 3 of 16 the American Transplant Congress 2019, Boston, MA.
- D. Kumar, M. Raynaud, P. Halloran, A. Loupy, J. Chang, J. Reeve, I. Yakubu, S. Bobba, L. Kamal, M. Levy, C. Bhati, P. Kimball, A. King, G. Gupta. Impact Of Belatacept Conversion On Renal Function, Histology And Gene Expression In Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection. Oral Presentation; 2019 American Transplant Congress. Boston, MA, U.S.A. 06/2019
- I. Moinuddin, D. Kumar, P. Halloran, L. Kamal, A. King, P. Kimball, M. Levy, C. Bhati, D. Massey, G. Gupta. Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies. Oral Presentation; 2019 American Transplant Congress. Boston, MA, U.S.A. 06/2019
- G. Gupta, D. Kumar, M. Raynaud, A. Loupy, J. Chang, J. Reeve, P. Sanghi, I. Yakubu, L. Kamal, M. Levy, C. Bhati, P. Kimball, A. King, H. Massey, P. Halloran. Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Interstitial Fibrosis and Tubular Atrophy. Oral Presentation; 2019 American Transplant Congress. Boston, MA, U.S.A. 06/2019
- Kumar D, Yakubu I, Cooke RH, Halloran PF, Gupta G. Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant. Am J Transplant. 2018 Jul 7. PMID: 29981184
- G. Gupta, S. Bobba, D. Contaifer, P. Kimball, A. King, D. Kumar, M. Levy, J. Stern, D. Kumar, Wijesinghe. A Pre-Transplant Blood-Based Lipid Signature for Prediction of AntibodyMediated Rejection in Kidney Transplant Patients. Poster Presentation; 2018 American Transplant Congress. Seattle, WA.
- Pooja Sanghi, Gaurav Gupta, Dhiren Kumar, Jeff Reeve, Marlon Levy, Amit Sharma, Hasan Fattah, Pamela Kimball, Hugh D Massey, Anne L King, Philip Halloran. Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression. Oral presentation at the American Transplant Congress
- Hitarth Dave, Luke Wolfe, Hasan Fattah, Dhiren Kumar, Anne L King, Marlon Levy, Adrian Cotterell, Amit Sharma, Chandra S Bhati, and Gaurav Gupta. Induction with T-cell Depletional Agents is Safe and Efficacious In the Very Elderly Kidney Transplant Recipients: An Analysis of the OPTN Database. Presented at the American Transplant Congress 2016.
- G. Gupta, A. Regmi, D. Kumar, S. Posner, M. P. Posner, A. Sharma, A. Cotterell, C. S. Bhati, P. Kimball, H. Davis Massey, A.L. King. Am J Transplant. 2015; May. Safe Conversion from Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients with Allograft Dysfunction.
- Gaurav Gupta, Hasan Fattah, Rivka Ayalon, Jason Kidd, Todd Gehr, Luis F. Quintana, Pamela Kimball, Salima Sadruddin, H. Davis Massey, Dhiren Kumar, Anne L. King, M.D., and Laurence H. Beck, Jr. submitted to the ‘Clinical Journal of the American Society of Nephrology’. Pre-transplant Phospholipase A2 Receptor Autoantibody Concentration is Associated with Recurrence of Membranous Nephropathy Post-Kidney Transplantation
- Anil Regmi, Omer Ali, Dhiren Kumar, Anne King, Gaurav Gupta. Late Recurrent UTIs in Kidney Transplant Patients: Risk Factors, Microbiologic and Antibiotic Resistance Patterns. Poster presentation at the American Transplant Congress 2015.
- Layal Abdel Rahman, Pamela Kimball, Anne King, Amit Sharma, Adrian Cotterell, Dhiren Kumar, Muhammad R. Qureshi, Felecia McDougan, and Gaurav Gupta. Intravenous Immunoglobulin and Rituximab Based Desensitization Is Ineffective for Highly Sensitized Patients. Poster presentation at the American Society of Nephrology Meeting 2014.
- Muhammad R Qureshi, Gaurav Gupta, Layal A Rahman, Marc P Posner, Amit Sharma, Martha Behnke, Stacey Posner, Dhiren Kumar, Anne L King. Minor Variations in Induction Rabbit Anti-thymocyte Globulin Dosing Are Not Associated with an Increased Risk of Infections or Rejection. Poster presentation at the World Transplant Congress 2014.
- Linatoc JAT, Ren Q, Behnke M, Sharma A, Posner M, Gehr T, King A. Effect of Hepatitis C Virus (HCV) Infection on the Outcome of Highly Sensitized Kidney Transplant Recipients in Modern Immunosuppression Era. Oral presentation, American Transplant Congress 2012.
- Linatoc JAT, Ren Q, Behnke M, Sharma A, Posner M, Gehr T, King A. Effect of Hepatitis C Virus (HCV) Infection on the Outcome of Highly Sensitized Kidney Transplant Recipients in Modern Immunosuppression Era. Oral presentation, Virginia Commonwealth University Resident Research Day. June 2012, Richmond VA.
- Gaurav Gupta, Julie Ann T. Linatoc, David Lee, Marc P Posner, Qing Ren, Anne L. King, Pamela Kimball. Incidence and Clinical Course of Antibody-mediated Rejection in Kidney Allografts associated with Non-HLA-antibodies targeting Angiotensin type 1 Receptor. Presented at American Society of Nephrology Meeting 2013.
- Julie Ann T. Linatoc, Anne King, Davis Massey, Gaurav Gupta. Relapsing-Remitting Course of Mixed Cryoglobulinemic Glomerulonephritis After Kidney Transplantation. Presented at National Kidney Foundation Meeting 2013.
Each fellow has three weeks of vacation per year. The time is generally taken as either one of the following:
- Three 7-day vacations
- One 7-day vacation and one 14-day vacation.
Additionally, each fellow is given five days off during the December holiday period.
Nephrology fellows do not take any in-house call. At night, the fellows provide at-home call for urgent clinical care questions and consults. Fellows come in for emergent consults, staffed with the on-call attending physician. Additionally, the attending physician provides back-up, supervision, and escalation for the fellow on-call. A fatigue policy is in place whereas fellows should expect coverage by a colleague or attending if they are too fatigued to work following a call. Nighttime at-home call is distributed amongst all fellows throughout the year of training.
Fellows cover VCU Hospital for approximately 6-18 weekends per year. When on call over a weekend, the fellows see all new consults at VCU during the day, which are staffed with the attending physicians on call. Additionally, the weekend on-call fellow rounds with the attending physician on existing consults.
Fellows average at least 1 day off in 7 when averaged over 4 weeks.
GME Resident & Fellow Well-Being
Graduate Medical Education training is not easy. With the GME Physician Well-being program, we first and foremost assert our commitment to your well-being, resilience and all aspects of a healthy lifestyle. VCU and VCUHealth are dedicated to ensuring that you have the tools you need to be your best. (Learn more)
All About VCU, VCUHealth, and RVA
First things first. We fondly refer to Richmond as RVA. People love this city because it’s awesome. And Virginia Commonwealth University is in the middle of it all. Learn more about VCU, VCUHealth, and RVA!
Class of 2021
Bhupinder Prajapati, MBBS
Residency: Internal medicine, SUNY Downstate, Brooklyn, NY
Sravanthi Paluri, MBBS
Residency: Interfaith Medical Center, Brooklyn, NY
Class of 2018
Ujwal Gautam, MBBS
Medical School: Institute of Medical Sciences, Varanasi, India
Residency: St. John’s Episcopal Hospital, Far Rockaway, NY
Irfan Moinuddin, MBBS
Medical School: Jinnah Medical College, Peshawar, Pakistan
Residency: St. Joseph Mercy – Oakland Program, Pontiac, MI
Class of 2017
Sindhura Bobba, MBBS
Medical School: Siddhartha Medical College, Government General Hospital, Vijayawada, India
Residency: Howard University Hospital, Washington, DC
Medical School: Sriram Chandra Bhanja Medical College, Cuttack, Orissa, India
Residency: Basic Physician Trianing, Royal Australasian College of Physicians. (RACP)
Fellowship: Nephrology Advanced Training Royal Australasian College of Physicians (RACP), Australia
Class of 2016
Medical School: Medical University of the Americas (Nevis) Saint Kitts and Nevis
Residency: Leonard J Chabert Medical Center, Houma, LA
The applicant should be an MD with three or more years of Internal Medicine residency training in an ACGME-accredited training program. A pass on USMLE Step 3 is a mandatory prerequisite for acceptance as a fellow.
Our institution can sponsor J-1 visas. H-1 visas might be available on a case by case basis.
- Curriculum Vitae
- USMLE score reports
- Medical school transcripts
- A personal statement
- 4 letters of recommendation, including one from your program director
- A photograph
If applicable, please provide the following:
- ECFMG certificate
- Medical School Diploma (with translation if necessary)
Interview dates for the 2021 Interview Season will be starting with August 1, 2020 and ending January 1, 2021.
Sample interview itinerary:
10:45 – Arrival
11:00 – 11:30 – Interview
11:30 – 12:00 – Interview/Tour with fellow
12:00 – 12:30 – Interview
12:30 – 01:30 – Transplant Conference
01:30 – 02:00 – Program Overview and Interview with PD
02:00 – 02:30 – Interview
02:30 – 03:00 – Interview
03:00 – 03:30 – Interview – Fellow
03:30 – 04:00 – Wrap up, Questions with PD
Attention: In support of our applicants, we will be flexible in providing virtual and on-site fellowship interview opportunities. We understand that applicants may have restrictions on travel during this time. Our interview schedule may change as we approach the late summer and fall. We appreciate your patience and understanding; we will absolutely work to accommodate all applicants as best possible during the COVID pandemic.